Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04663607 · ClinicalTrials.gov registry record · NA
Mobile Strategy to Reduce the Risk of Recurrent Preterm Birth
A NA study of Preterm Birth, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 221
- Enrollment target
- 2
- Study locations
NCT04663607: Completed NA study of Preterm Birth, sponsored by Stanford University.
NCT04663607 is a NA study of Preterm Birth that has completed, run by Stanford University. The registered enrollment target is 221 participants, below the 4,404-participant average among 39 other Preterm Birth trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04663607, a NA study of Preterm Birth, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 221 participants
- Enrollment target
- 2
- Study locations
Study Summary
Preterm births are defined as delivery prior to 37 weeks gestation and account for 35% of infant deaths in the first year of life. Early preterm birth are deliveries prior to 32 weeks gestation and account for more than 70% of neonatal deaths and 36.1% of overall infant mortality. Women who have delivered a preterm infant and who have a short pregnancy interval (time between giving birth and subsequent conception) have an increased risk of preterm birth in subsequent pregnancies. The investigators hope to understand if a mobile health strategy can be used to reduce spontaneous preterm births via improved patient engagement, care coordination, and adherence to recommended care vs a traditional paper-based health strategy.
Primary Outcome
Time interval from most recent birth to next conception
Conditions Studied
Interventions
- BEHAVIORAL Use of PretermConnect App
Study Locations (2)
Pennsylvania
- UPMC Magee-Womens Hospital - Pittsburgh
- UPMC Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2021-10-07 |
| Est. Completion | 2025-07-18 |
| Phase | NA |
What the finished NCT04663607 record still lists
NCT04663607 is an interventional study that assigns participants to a tested intervention. The registered 221 participants enrollment target is mid-sized for trials with a published cap, below the 4,404-participant average among 39 other Preterm Birth trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Preterm Birth appearing as the primary indexed condition, and to 1 intervention - of which Use of PretermConnect App is the first listed.
NCT04663607 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04663607 about?
NCT04663607 is a clinical study titled "Mobile Strategy to Reduce the Risk of Recurrent Preterm Birth". Preterm births are defined as delivery prior to 37 weeks gestation and account for 35% of infant deaths in the first year of life. Early preterm birth are deliveries prior to 32 weeks gestation and account for more than 70% of neonatal deaths and 36.1% of overall infant mortality. Women who have del...
What is the current status of trial NCT04663607?
This trial is currently completed. It is a NA study. The enrollment target is 221 participants. The study started on 2021-10-07. Estimated completion is 2025-07-18.
What conditions does trial NCT04663607 study?
This clinical trial studies the following conditions: Preterm Birth.
What interventions are being tested in trial NCT04663607?
The interventions under investigation include: Use of PretermConnect App (BEHAVIORAL).
Who is sponsoring clinical trial NCT04663607?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04663607 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04663607's enrollment target sits among peer trials
221 20th of 39 higher than 20 of 39 other Preterm Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Preterm Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transition From Donor Milk: a Feasibility Study
RECRUITING · NA
-
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
RECRUITING · NA
-
Stress Phenotypes and Preterm Birth
RECRUITING · NA
-
Optimal Timing of Routine Cervical Length Measurements During Anatomy Survey
RECRUITING · NA
-
Bilateral Infant Stimulation Study
RECRUITING · NA
-
Effect of Support for Low-Income Mothers of Preterm Infants
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03170440 · 221 participants · NA
Non-invasive Nerve Stimulation for PTSD and Sleep
- NCT04939610 · 222 participants · Phase 1
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- NCT05424783 · 222 participants
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)
- NCT05568264 · 222 participants · NA
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI